RhumbLine Advisers’s Biofrontera AG American Depositary Shares BFRA Stock Holding History

RhumbLine Advisers’s Portfolio BFRA Stock Details BFRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-288	Closed	-$714	–	4420
2024 Q1	$714	Hold	288	–	–	﹤0.01%	4170
2023 Q4	$714	Hold	288	–	–	﹤0.01%	4178
2023 Q3	$714	Hold	288	–	–	﹤0.01%	4209
2023 Q2	$714	Buy	+288	New	+$714	﹤0.01%	4302

RhumbLine Advisers's BFRA Position: Q2 2024 in Review

RhumbLine Advisers sold out of Biofrontera AG American Depositary Shares (BFRA) in Q2 2024, closing a stake of 288 shares — an estimated $714 sold.

RhumbLine Advisers first reported a position in BFRA in Q2 2023 and held it in 4 quarters. The position peaked at $714 in Q1 2024. 0 funds tracked by Wall St. Rank hold BFRA as of Q2 2024.

RhumbLine Advisers reported no remaining Biofrontera AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
RhumbLine Advisers sold 288 Biofrontera AG American Depositary Shares shares in Q2 2024, an estimated $714.
RhumbLine Advisers first reported a position in Biofrontera AG American Depositary Shares in Q2 2023 and held it in 4 quarters.
RhumbLine Advisers's Biofrontera AG American Depositary Shares position peaked at $714 in Q1 2024.
0 funds tracked by Wall St. Rank held Biofrontera AG American Depositary Shares as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.